companies innovating in obesity treatment glp-1 drugs 2025

companies innovating in obesity treatment glp-1 drugs 2025 Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, and Providers GLP-1: Transforming weight loss and

Name: companies innovating in obesity treatment glp-1 drugs 2025 Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, and Providers GLP-1: Transforming weight loss and
Brand: www.keygrove.com
SKU: 76240508307
Price: 24.05 USD
Availability: InStock
Rating: 4.5085 (8 reviews)

SKU: 76240508307

4.5

USD24.05 USD60.05

Pay in 4 interest-free payments of $6.01 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

L., Leonhardt, B

Common adverse events and side effects Tirzepatide may cause common side effects in irritable bowel syndrome, such as diarrhea, constipation, nausea, vomiting, upper abdominal discomfort, decreased appetite, and abdominal pain